chr15-78500185-T-C
Position:
Variant summary
Our verdict is Benign. Variant got -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_004136.4(IREB2):c.*2042T>C variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.398 in 151,970 control chromosomes in the GnomAD database, including 12,202 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.40 ( 12198 hom., cov: 31)
Exomes 𝑓: 0.47 ( 4 hom. )
Consequence
IREB2
NM_004136.4 3_prime_UTR
NM_004136.4 3_prime_UTR
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -0.594
Genes affected
IREB2 (HGNC:6115): (iron responsive element binding protein 2) The protein encoded by this gene is an RNA-binding protein that acts to regulate iron levels in the cells by regulating the translation and stability of mRNAs that affect iron homeostasis under conditions when iron is depleted. When iron levels are low, this protein binds to iron-responsive elements (IRES), stem-loop structures located either in the 5' or 3' UTRs. Binding to the 5' UTR represses translation, while binding to the 3' UTR inhibits mRNA degradation. When iron is found in the cell, this protein is degraded in a F-box and leucine rich repeat protein 5-dependent manner. Variants in this gene have been associated with lung cancer and chronic obstructive pulmonary disease (COPD). Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Aug 2017]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.87).
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.494 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
IREB2 | NM_004136.4 | c.*2042T>C | 3_prime_UTR_variant | 22/22 | ENST00000258886.13 | NP_004127.2 | ||
IREB2 | NM_001320941.2 | c.*2042T>C | 3_prime_UTR_variant | 21/21 | NP_001307870.2 | |||
IREB2 | NM_001320942.2 | c.*2042T>C | 3_prime_UTR_variant | 22/22 | NP_001307871.2 | |||
IREB2 | NM_001354994.2 | c.*2042T>C | 3_prime_UTR_variant | 22/22 | NP_001341923.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
IREB2 | ENST00000258886.13 | c.*2042T>C | 3_prime_UTR_variant | 22/22 | 1 | NM_004136.4 | ENSP00000258886 | P1 |
Frequencies
GnomAD3 genomes AF: 0.398 AC: 60382AN: 151818Hom.: 12176 Cov.: 31
GnomAD3 genomes
AF:
AC:
60382
AN:
151818
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.471 AC: 16AN: 34Hom.: 4 Cov.: 0 AF XY: 0.455 AC XY: 10AN XY: 22
GnomAD4 exome
AF:
AC:
16
AN:
34
Hom.:
Cov.:
0
AF XY:
AC XY:
10
AN XY:
22
Gnomad4 AMR exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.398 AC: 60434AN: 151936Hom.: 12198 Cov.: 31 AF XY: 0.401 AC XY: 29756AN XY: 74250
GnomAD4 genome
AF:
AC:
60434
AN:
151936
Hom.:
Cov.:
31
AF XY:
AC XY:
29756
AN XY:
74250
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1752
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at